Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genital Neoplasms, Female × Surgical Procedures, Operative × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 66 Breast Neoplasms 56 Rectal Neoplasms 48 Esophageal Neoplasms 39 Stomach Neoplasms 38 Glioblastoma 37 Lung Neoplasms 31 Colorectal Neoplasms 30 Brain Neoplasms 30 Squamous Cell Carcinoma of Head and Neck 24 Pancreatic Neoplasms 23 Neoplasms 23 Glioma 22 Neoplasm Metastasis 20 Sarcoma 19 Head and Neck Neoplasms 19 Astrocytoma 18 Carcinoma, Hepatocellular 16 Esophageal Squamous Cell Carcinoma 15 Recurrence 14 Ovarian Neoplasms 14 Melanoma 13 Gliosarcoma 13 Colonic Neoplasms 13 Central Nervous System Neoplasms 13 Adenocarcinoma Of Esophagus 12 Urinary Bladder Neoplasms 11 Prostatic Neoplasms 11 Uterine Cervical Neoplasms 10 Oropharyngeal Neoplasms 10

Interventions

pembrolizumab 3 Educational Status 3 Therapeutic Touch 2 Surveys and Questionnaires 2 Standard of Care 2 Radiotherapy 2 Palliative Care 2 Paclitaxel 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Gemcitabine 2 Early Intervention, Educational 2 Carboplatin 2 temsirolimus 1 rucaparib 1 relacorilant 1 olaparib 1 nilotinib 1 liposomal doxorubicin 1 lenvatinib 1 fosaprepitant 1 atezolizumab 1 argatroban 1 anlotinib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Topotecan 1 Thrombopoietin 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06089083 2026-01-26

PROOF

University of California, San Francisco

Frailty, Genital Neoplasms, Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡